Detalles de la búsqueda
1.
Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea.
J Korean Med Sci
; 38(34): e269, 2023 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644683
2.
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023.
J Korean Med Sci
; 38(46): e396, 2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38013649
3.
Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study.
Vaccine
; 42(7): 1440-1444, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365479
4.
Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea.
Int J Infect Dis
; 135: 95-100, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572956
5.
Estimating the number of severe COVID-19 cases and COVID-19-related deaths averted by a nationwide vaccination campaign in Republic of Korea.
Osong Public Health Res Perspect
; 14(3): 164-172, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415433
6.
Age-specific Risk of SARS-CoV-2 Reinfection During Omicron Outbreaks, South Korea.
Pediatr Infect Dis J
; 42(8): e296-e297, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37235758
Resultados
1 -
6
de 6
1
Próxima >
>>